India is ideal destination for clinical research, due to huge disease burden: Dr Anil Pareek

Interacting with ETPharma, Dr Anil Pareek, President, Medical Affairs & Clinical Research, Ipca Laboratories shared the need for early exposure to translational medicine, highlighting the need for innovation in the disease and therapy space. He highlighted the need for good disease insights as that leads to innovation in the treatment or therapy for that disease.

[@Buy_YT_Views_492]

so, when are you realising your next video?